Europe — EMA
Notezine (Diethylcarbamazine Citrate)
GNH USA supplies Notezine (Diethylcarbamazine citrate), a antifilarial anthelmintic for lymphatic filariasis, loiasis and onchocerciasis.
Request sourcing
What is Diethylcarbamazine Citrate?
Diethylcarbamazine citrate, the active ingredient in Notezine, is an anthelmintic presented as an oral dosage form for oral use. It is employed to treat infections caused by filarial parasites, primarily in endemic regions and in patients requiring antifilarial therapy. GNH USA supplies Notezine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Diethylcarbamazine Citrate used for?
Diethylcarbamazine citrate acts on filarial parasites and is indicated for several filariasis‑related conditions. - Lymphatic filariasis: reduces microfilarial load and helps prevent disease progression. - Loiasis: eliminates Loa loa microfilariae and alleviates ocular and subcutaneous manifestations. - Onchocerciasis: decreases microfilarial density, contributing to control of river blindness.
What are the side effects of Diethylcarbamazine Citrate?
Adverse reactions may occur with diethylcarbamazine citrate therapy.
Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Abdominal pain: cramp‑like discomfort. - Fever: low‑grade temperature elevation. - Itching: pruritic skin sensations.
Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Neutropenia: marked reduction in neutrophil count. - Encephalopathy: altered mental status or seizures. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiac arrhythmia: irregular heart rhythm.
What precautions apply to Diethylcarbamazine Citrate?
Careful assessment and monitoring are recommended when prescribing diethylcarbamazine citrate. - Renal function assessment: evaluate kidney status before initiation. - Allergic reaction monitoring: watch for signs of hypersensitivity. - Known hypersensitivity avoidance: do not use in patients with documented allergy to the drug. - Cardiac disease caution: use carefully in patients with pre‑existing heart conditions. - Pregnancy safety: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep in the original pack, protect from moisture.
What does Diethylcarbamazine Citrate interact with?
Diethylcarbamazine citrate may interact with other medicines, requiring attention to co‑administration.
Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - MAO inhibitors: can potentiate hypotensive effects. - Other filaricidal agents: combined use may raise toxicity.
Moderate Interactions (Monitor Closely): - CYP450 substrates: diethylcarbamazine may alter plasma concentrations of drugs metabolised by these enzymes. - Antihistamines: may mask early allergic signs. - Diuretics: concurrent use may affect electrolyte balance.